natural glp-1 receptor agonists show promise in treating substance use disorders 20 Companies in Glucagon-Like Peptide-1

Ending coverage for GLP-1 obesity drugs would be in line with current financial trends in both public and private insurance companies but could result in health inequities and less comprehensive coverage for a large segment of Rhode Islands population, the budget note reads

It may help dull-looking skin appear clearer and more balanced over time

Li C, Xiong Y, Fu Z, Ji Y, Yan J, Kong Y

This roundtable examines the erosion of democracy in urban development as a critical challenge in the context of the multi-crisis era of the society, marked by climate change, economic instability, social inequality, and political polarization